Northwestern Mutual Wealth Management’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-117
Closed -$8K 2762
2019
Q3
$8K Sell
117
-409
-78% -$28.1K ﹤0.01% 1991
2019
Q2
$31K Sell
526
-264
-33% -$15.6K ﹤0.01% 1571
2019
Q1
$55K Buy
790
+493
+166% +$36.6K ﹤0.01% 1311
2018
Q4
$19K Buy
297
+56
+23% +$3.93K ﹤0.01% 1620
2018
Q3
$17K Buy
241
+219
+995% +$12.8K ﹤0.01% 1742
2018
Q2
$1K Buy
+22
New +$873 ﹤0.01% 2318

Northwestern Mutual Wealth Management's GHDX Position: Q4 2019 in Review

Northwestern Mutual Wealth Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 117 shares — an estimated $8K sold.

Northwestern Mutual Wealth Management first reported a position in GHDX in Q2 2018 and held it in 6 quarters. The position peaked at $55K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Northwestern Mutual Wealth Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 117 Genomic Health, Inc. shares in Q4 2019, an estimated $8K.
  • Northwestern Mutual Wealth Management first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 6 quarters.
  • Northwestern Mutual Wealth Management's Genomic Health, Inc. position peaked at $55K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.